Pediatrics
Bevacizumab use in preemies associated with disabilities
(HealthDay)—Bevacizumab (Avastin) used to treat retinopathy of prematurity (ROP) may be linked to serious disabilities such as cerebral palsy and hearing loss, according to a study published online March 17 in Pediatrics.
Mar 21, 2016
0
6
